Recombinant Zebrafish WNT1

• Cat.No.: WNT1-7923Z
• Product Overview: Recombinant Zebrafish WNT1 full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Zebrafish
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 oC for short term. For long term storage, store it at -20 oC～-80 oC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: wnt1 wingless-type MMTV integration site family, member 1 [ Danio rerio (zebrafish) ]
• Official Symbol: WNT1
• Gene ID: 30128
• mRNA Refseq: NM_001201398
• Protein Refseq: NP_001188327
• UniProt ID: B3DI55

Reviews

10/10/2020

The manufacturer's commitment to providing high-quality proteins is evident in their meticulous production process, ensuring the purity and reliability of the WNT1 protein.

10/25/2019

The WNT1 protein is characterized by its exceptional quality, making it an ideal choice to fulfill my experimental requirements.

05/07/2017

the WNT1 protein's high quality and its compatibility with my experimental needs, coupled with the manufacturer's excellent technical support, create a valuable alliance that contributes to successful research endeavors.

Q&As

Can WNT1 be used as a diagnostic marker for certain cancers?

Research suggests that elevated levels of WNT1 may serve as a diagnostic marker for certain cancers, aiding in early detection.

Are there therapeutic interventions targeting WNT1 for neurodegenerative diseases?

Some studies are exploring the modulation of WNT1 signaling as a potential therapeutic approach for neurodegenerative diseases.

Is WNT1 involved in bone formation and regeneration?

Yes, WNT1 plays a crucial role in bone development and regeneration, and its manipulation is being explored for potential applications in bone-related disorders.

Are there any ongoing clinical trials targeting WNT1 in cancer treatment?

Yes, some clinical trials are exploring the inhibition of WNT1 as a potential strategy for treating specific types of cancers.

How does WNT1 relate to neurodegenerative diseases?

WNT1 has been implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, where its dysregulation may contribute to the pathology.